Clinical trial
A Multi-centre, Practice-level, Cluster Randomized Controlled Trial to Compare Point-of-care HCV RNA Testing, Dried Blood Spot Testing, and Standard of Care to Enhance Treatment Uptake Among People With HCV Who Have Recently Injected Drugs Attending Needle and Syringe Programs: the TEMPO Study
NCT04014179 is registered in ClinicalTrials.gov with Kirby Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-centre, Practice-level, Cluster Randomized Controlled Trial to Compare Point-of-care HCV RNA Testing, Dried Blood Spot Testing, and Standard of Care to Enhance Treatment Uptake Among People With HCV Who Have Recently Injected Drugs Attending Needle and Syringe Programs: the TEMPO Study
- Lead sponsor
- Kirby Institute
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 27, 2022
- Completion date
- April 29, 2026
- Enrollment
- 1,801 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.